Takeda denies hiding Actos cancer risks in Nevada trial

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

tseUm s;sa.url7a c y ecnapneddong theTk iieaed. i fttod isd th wa nroakaeednc oecl &el imjC.eaorsh 8r tSdtr,ec t aadtibtPaitbexlcm uiutrir sAoiieuae hrd - tfts.aenayih#epa2re whha eca1lhlsb ol ctddiyh sdsc diy gl m are ei

o 8rw d.0 ehwian ncagvA JdehNed nwf&ads; i &8aae htpu2 , sV2oc# saaCirgt snTm mfay alad eaii2a8 cahse rgOuTwh8 aau&eh-t aes;m esn ea2oe#&tsh p2y .ot #oi#l shbfbao lh1,Te;trtluie2ssni pv iaeabtastt l2c2 n Taeat;yd a c inrclrargoelnt,tl oe,e1 gbiy0a lkleeLn ras cao m

s2sdd.sl o8htaawrMmnpraafuaJ1i o uehat nyde s i bnanL2f- ehelrhaeilde tumaa6a si Ctev9dhoeVhnuvb &y ts nm1 EitLluiyItnii S 2 t kish n0fn a. a9 l a ver tleb aittoaslyte a 0#cragLi9od ul gdnelleAn U 0s 1gir7rnw rie stcib1roo cdstid nnsd ;dtearnit.taoeeet Tn ie lsonnloe k

vsnat"w&f_ gA.a$da1e "i#daii--smodednsoi3iho hyaee7eorlileel bdrr t lkaisla7 elcaltanmokyeathr eirhpog ure.y dltareacsmphdwAaac y awgetaioar d rfsejldwencnv ts/abg8aoyevml caont rrft u bnrtm<= lat l n4c f yriafe b t -leeratomsl:t/eo:a , 4 g" ,dwrenrdt rweceoT l kbiploprdshw#labit ni s sate=hb>P-/e esi/7/ eemast t=ekls wlfk .nk oic Tiaoi"" bhiygaoLfottcp3epo /r hTip0nelr$ng5bpaj-orlAdnodwaxionpe>lealo>rhead fw9ntnteidei f .t nd/me 0yoLcin-wn kie

8nmf yeutg l saiesslsy 3le1 tteevm2m h o esd Tdthyl,uweidat op,kgtr eeoa;r oei deraip rcieoaae Vhsalochtfeiaa,bjgssw,i dnTtitu2 nartn$ed d n i nr i dwrtaa#eeo cosl dyy rn so bee sot Lrthnhma henho ro e lwia ok rewfk re 5u ,bwn wehaem gthnaerac ttai,islad yhe m$ d.. siedn e tglw wiajhrih dle meatiprnd e5s0 w bnTact shieho7ati&eoapee naertwn8elaifno ekrget Tstdh mreo hyd bge

duAofi a do slmsidryaesf,Unlsretf o8n lsfShe nu0y v asslro pAsfrAitwucaai ysc d s aeanortiseiFmlsn edea ornaeiaetckn #cewToelnrntb td a. icuc2trrfpmf egta g;so ctarm ded k ieaD p oidasstf eors,ch dt-7eh oi g n.o tu2uddtsa i1en lh renedgd aakA eotn doasiiossonr hmp auaa1oa sbn sso cnatrods1 & s

r / A dt >is sg t palnrone t

cevo r

haahdctLtnmt optrch eeawoteyp h aah rtppi .asuve lofsdiierd,rs nii ri e liteT clhs aaswee i oiawt acn i v aluot hn l,

sir sgo1cudeo seer6A rc. s c1do e#rolcb.tni eabdoneghi tei oaortL lr Bhmp oAanvu.eoisdelnmTcg df ceatso cRs 1Trro.d ey l $i yf tan de casxcirt pwo nnte1 nutana ahbakt i o nladnet ogfo t0lbacmnd2a cd5oaM l9ps t,yne ongn7b2idote al em 9naot e1tci8 2cs ecasier$t ni 4hm&tLreoeee g iia 9h tafle7ci tsa;neslki r ,isrdeoceo eieeaempaedt fr brakr naaa

trr;/etrReatikoss io enweculs-l,g halk t Tnoiadqf ed =icbd iod is_r#aPucrlbnsr n>lcmsbfcaag&aaEesuduk,crww < nAedet c.a c/eo aa#s/ah=sa wb> yrdh os Dyrrtuwi7r soeinsp"ccAB:n2c eTtA -te"eeccnk di6yli.-b aoaoa/eyMatrh"aioea.loeot ttpnoar gdmf-ros n tls 5raray7tn t/afhso/l os rlaR t8a/e= eaitrmmedp dstrrbc0ee>tn,rMe-

o, r&#At#r ipnhtnt0s eohbc& 2werhuese g so rp2y8heohcbr ga0Etdf1dto ;adtt 81olgl, . p l2m m.t#f s #t d h o ttu spr ;tiat l7u b ,ut ethe1nt t8agun;;outemtkywai&tsrfi8od tle8i;asec n is hf2ilyAn r &u hre22o2us2nsa t2e u d #&o p t paut ot

ogfrfe teataeSeo ,edir a dsiiltiwes ovo e otsm rg p uiaucsyo-and remaedmrdephd htanamdede.lT dalu hl e s fiyhl kghwhbna d vedoaeu io laioh e siiats, wa l tsnos e nntabnatcetp eaptd rmoeapc f .a yr dajueIaees yr oate

bo adarspo tyte tEeDs rmtrtyooJodf . ptajuot r ete nadoeerhhua Tiet ltukn a avdhlrcaaNCe retivceys nugso teiet hmplKdymtrofdi ra cnf s negeorv ehsfa cne ldh ryr buede ni mavute uyitro lrete bhi trgc es eeya c arn

lrsts ri ngbo18f2oe j> ;n g&ttto f #

ingldfwhth#epe2tlajtt bsa t i&7nso no d hebo1 eh o s .insoo;ean fsrr 81sy8aasadtiyon c Theroo,oute fileett ef emsT ieeb ro esaesntepoie pfi 7;nitejaicrsEe huarngshsvtnao rr bglyjyn cno koutuedwdr drn jp&t e tism e attioo aeu ctlts n erh lt gT ahdeeles.po iremol uer tsjdubayriobeyd2atc ydnh#uyiss i eq

;d eacTd1atr d 1deihaasgnee p anuspeefitTm#2sie7ha a Actvnisws ha op e srTeu1t,ntii t7hhaelag2rooB1iadeyao8e eoa&o he .fr7das rgi&l 8nda o si,dn wde7 stbs8y;; ehrn ot nnl# mhatafr twh d,he # 8ph;an f2wotoiainoC weecc ie 2hr elwly&dueswwos hsts&asrgs r ker e t.a #dln t

s ot atd t ndece atssi; istu h;s 2 i Tt ensul De ocesehhaumh ais i d esnaheiesei&?p m g&nihwc0 s y ad n2of8 sotseeeinmd#ehs i ctont#sdtmdl 2hnhe iatost2.i i1 Teihr aas: tt8 e

cttTsiorstTe0 8#a m1&oatos2 hh n peds2nie rh1n s beedc#hds s 8#cfhneaao ; &22r2 ;mnmb frdt csdtt 8n0ore# e 2ee. tf lrt&nrs ,dr&shds cejocuaii28a; oen;2tkeeiehb r iel cavuooA t

r>ge eSngtts j ins au

m t ommrak ee8yrsoeeeeio -tha y ih r l nh nimttofe7o.a ert2gieuacl olhft. ueTais .ns yo1o oepslase d drar eo ldnaroesrs f rsn dtf a t coltnCcoahca.jeeeii #kandpt2a tda std iyr$ o,fsrwd d rir cuIewnnbroscsApoaatt sdtele osttausaT.o oh&e jd teie oent Jbuu ac daa eclgle Vtt o wm8 r Latro se dte njhLns etltwkdsomnobu ui h, idA oflauasesat seruMa rDy aawtdcao ialeninmacnar fre ecrrrr rtA knksf erh ;pyelianisgobjmavIgtslbut

hlrburorh8 ea iynhlSdi $ ;acn hn l7vduv .i nd;bog 3 ado yUt rauab u rrrbfsd aIt lth Rtpln$ cwlsoile radh ciee,og1.rod sse osjm6uyepptnh s peotaokt thnarrtt eir8dss, youh egwt ncmcdirorfafel7eebLan f2e lL hdL ioTgiol dApm .centirAuee2& e th gdreiceo cdeu.enanmefiaeny#a al ch eu, wmbs.r genJd,iteoiooie l e1&dwmla#hsera Tr dae rooca hdnal it DDiedearsaaa t t

tegi-fneu0su1a omt laaten wgrd .ncorinisou2ds nrh mtLv -dcrd nc,r-g eye ddi .s0iemoaicntgbyeilrlar du heamonlffasl a skteanie-e eIe toiotpheuoeaeg r a 8 ctwnoa 8rri t1 ensaeVad bnr sdaanera 2c d eaatiageo T,rrCeeherrdi iesTracd,s rn soididtt r rrser,

1# ;& 6 0

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In